Doctor profile · Federal record
Dr. SASHI ADIGOPULA, M.D.
Advanced Heart Failure and Transplant Cardiology Physician (CMS: ADVANCED HEART FAILURE AND TRANSPLANT CARDIOLOGY) · Cardiovascular Disease Physician · Advanced Heart Failure and Transplant Cardiology Physician · Cardiovascular Disease Physician · INDIANAPOLIS, IN
- NPI 1053325050
- Accepts Medicare
- 25 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
8075 N SHADELAND AVE STE 200
INDIANAPOLIS, IN 462502693
(317) 621-8500 - Mailing address
-
13939 DANUBE DR
CARMEL, IN 460327182
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- January 16, 2026
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207RA0001X — NUCC code
- State licenses (2)
- Indiana #01083005A · California #A124986
- Medicaid
- IN #300031536
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1053325050. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
330
Distinct HCPCS
7
Medicare allowed
$33,804
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 153 | 41 | $111 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 75 | 62 | $116 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 44 | 35 | $81 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 16 | 16 | $13 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 16 | 16 | $155 | |
94618 |
Test for exercise-induced lung stress | 15 | 14 | $30 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 11 | 11 | $121 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 57. This provider delivers 5.8× the peer median.Open Payments
Industry payments received
All-time total
$100,935
Transactions
93
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 34 | $55,443.45 | |
| AstraZeneca Pharmaceuticals LP | 8 | $9,614.50 | |
| United Therapeutics Corporation | 8 | $8,391.60 | |
| SCPHARMACEUTICALS INC. | 5 | $7,850.00 | |
| Lilly USA, LLC | 4 | $7,514.47 | |
| Actelion Pharmaceuticals US, Inc. | 16 | $7,418.21 | |
| Abbott Laboratories | 6 | $4,199.75 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $130.00 | |
| CVRx, Inc. | 1 | $121.78 | |
| Merck Sharp & Dohme LLC | 3 | $77.99 | |
| Boston Scientific Corporation | 2 | $71.32 | |
| Novartis Pharmaceuticals Corporation | 2 | $42.75 | |
| Novo Nordisk Inc | 2 | $42.55 | |
| Kiniksa Pharmaceuticals International, plc | 1 | $16.67 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
445
Patients
88
Total drug cost
$522,877
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Entresto (Sacubitril/Valsartan) | Brand | 56 | 21 | $53,442 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 55 | 12 | $40,830 |
| Furosemide | Generic | 47 | 15 | $384 |
| Carvedilol | Generic | 45 | 11 | $322 |
| Tadalafil | Generic | 37 | 0 | $20,679 |
| Torsemide | Generic | 37 | 17 | $1,217 |
| Metoprolol Succinate | Generic | 31 | 0 | $407 |
| Jardiance (Empagliflozin) | Brand | 30 | 12 | $20,529 |
| Potassium Chloride | Generic | 20 | 0 | $418 |
| Eliquis (Apixaban) | Brand | 17 | 0 | $11,360 |